Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis.

RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis. J Osteoporos. 2011; 2011:941310.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.